News

“Our Advocacy Really Prevented an Epidemic”: Updates from Zambia and Ethiopia

We interviewed two of our partner civil society organizations (CSOs) who successfully advocated for domestic funding in epidemic preparedness as part of the first cohort of the Advocacy Accelerator program (2024-2025). What we learned: The impacts continue well beyond after the program ends.

June 2, 2026 Announcement

The Long Walk to a Vaccine: What One Kenyan Mother's Journey Means for Funding Decisions

Past Tinamoi and through Mikuu, Sheila Chepkoi walks with her youngest child on her back and worry in her chest. From her home in Baringo County, in Kenya's Rift Valley, the nearest health facility is hours away on foot, and she has no money for transport. She walks because she knows what a missed vaccine can cost her child.

Immunization Kenya

“Our Advocacy Really Prevented an Epidemic”: Updates from Zambia and Ethiopia

Filter

New GHAI Public Comment Outlines Practical Steps to Strengthen Addiction Treatment and Recovery

Transforming the Narrative: How Strategic Advocacy is Rewriting Kano State’s Noncommunicable Disease Story

The ₦2.48 Trillion Question: Will Nigeria’s Heart Beat Faster or Falter in 2026?

Celebrating One Year of HATCH: A Global Hub for Public Health Advocacy

How Big Tobacco Helped Build the Ultra-Processed Products Industry — and Why That Matters Now

Statement of the Campaign for Tobacco-Free Kids, Global Health Advocacy Incubator to the Multi-Stakeholder Hearing on Pandemic Prevention, Preparedness and Response (PPPR)

Funding the 2026 National Drug Control Strategy: What is at Stake in FY 2027

Protecting Children on the Road: Q&A with Partner Asia Injury Prevention Foundation on Policy Wins and What's Next

The Long Walk to a Vaccine: What One Kenyan Mother's Journey Means for Funding Decisions

Jamaica's Tax on Sweetened Beverages Takes Effect